In reference to Squamous cell carcinoma associated with intralesional injection of cidofovir for recurrent respiratory papillomatosis.
Preuss
Simon F
SF
Quante
Gero
G
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D002294:Carcinoma, Squamous Cell / Q000139:chemically induced*; D000077404:Cidofovir; D003596:Cytosine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D006801:Humans; D015552:Injections, Intralesional / Q000009:adverse effects; D016609:Neoplasms, Second Primary / Q000139:chemically induced*; D063065:Organophosphonates / Q000008:administration & dosage / Q000009:adverse effects*; D010212:Papilloma / Q000188:drug therapy* / Q000473:pathology / Q000821:virology; D011230:Precancerous Conditions / Q000188:drug therapy* / Q000473:pathology; D014134:Tracheal Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000821:virology
D000970:Antineoplastic Agents; D063065:Organophosphonates; D003596:Cytosine; D000077404:Cidofovir